Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Long-term soluble Abeta1-40 activates CaM kinase II in organotypic hippocampal cultures.

Tardito D, Gennarelli M, Musazzi L, Gesuete R, Chiarini S, Barbiero VS, Rydel RE, Racagni G, Popoli M.

Neurobiol Aging. 2007 Sep;28(9):1388-95. Epub 2006 Jul 18.

PMID:
16846668
2.

Alpha2beta1 and alphaVbeta1 integrin signaling pathways mediate amyloid-beta-induced neurotoxicity.

Wright S, Malinin NL, Powell KA, Yednock T, Rydel RE, Griswold-Prenner I.

Neurobiol Aging. 2007 Feb;28(2):226-37. Epub 2006 Jan 18.

PMID:
16448724
3.

Astrocyte- and hepatocyte-specific expression of genes from the distal serpin subcluster at 14q32.1 associates with tissue-specific chromatin structures.

Gopalan S, Kasza A, Xu W, Kiss DL, Wilczynska KM, Rydel RE, Kordula T.

J Neurochem. 2005 Aug;94(3):763-73. Epub 2005 Jun 22.

4.

Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death.

Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, Rydel RE.

J Neurosci. 2005 Feb 2;25(5):1071-80.

5.
6.

Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses.

Wu CC, Chawla F, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE.

Proc Natl Acad Sci U S A. 2004 May 4;101(18):7141-6. Epub 2004 Apr 26.

7.

Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.

Reilly JF, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4837-42.

8.

Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes.

Kasza A, Kiss DL, Gopalan S, Xu W, Rydel RE, Koj A, Kordula T.

J Neurochem. 2002 Nov;83(3):696-703.

9.

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro.

Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, Brachova L, Yan SD, Walker DG, Shen Y, Rogers J.

Glia. 2001 Jul;35(1):72-9.

PMID:
11424194
10.

Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition.

Tucker HM, Kihiko-Ehmann M, Wright S, Rydel RE, Estus S.

J Neurochem. 2000 Nov;75(5):2172-7.

11.
12.

The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.

Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ.

Biochemistry. 2000 Sep 5;39(35):10831-9.

PMID:
10978169
13.

Inflammation and Alzheimer's disease.

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T.

Neurobiol Aging. 2000 May-Jun;21(3):383-421. Review.

14.

The plasmin system is induced by and degrades amyloid-beta aggregates.

Tucker HM, Kihiko M, Caldwell JN, Wright S, Kawarabayashi T, Price D, Walker D, Scheff S, McGillis JP, Rydel RE, Estus S.

J Neurosci. 2000 Jun 1;20(11):3937-46.

15.
16.

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J.

Am J Pathol. 1999 Sep;155(3):853-62.

17.

Human amylin induces "apoptotic" pattern of gene expression concomitant with cortical neuronal apoptosis.

Tucker HM, Rydel RE, Wright S, Estus S.

J Neurochem. 1998 Aug;71(2):506-16.

18.
19.

Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction.

Estus S, Tucker HM, van Rooyen C, Wright S, Brigham EF, Wogulis M, Rydel RE.

J Neurosci. 1997 Oct 15;17(20):7736-45.

20.

Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.

Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, Mattson MP.

J Neurochem. 1996 Nov;67(5):1882-96. Erratum in: J Neurochem 1997 Mar;68(3):1331.

PMID:
8863493
21.

Amyloid beta-mediated oxidative and metabolic stress in rat cortical neurons: no direct evidence for a role for H2O2 generation.

Zhang Z, Rydel RE, Drzewiecki GJ, Fuson K, Wright S, Wogulis M, Audia JE, May PC, Hyslop PA.

J Neurochem. 1996 Oct;67(4):1595-606.

PMID:
8858944
22.

Alzheimer's disease. Amyloid ox-tox transducers.

Mattson MP, Rydel RE.

Nature. 1996 Aug 22;382(6593):674-5. No abstract available.

PMID:
8751434
23.

Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells.

Gitter BD, Cox LM, Rydel RE, May PC.

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10738-41.

24.

Therapeutic approaches related to amyloid-beta peptide and Alzheimer's disease.

Schenk DB, Rydel RE, May P, Little S, Panetta J, Lieberburg I, Sinha S.

J Med Chem. 1995 Oct 13;38(21):4141-54. Review. No abstract available.

PMID:
7473539
25.

Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury.

Smith-Swintosky VL, Pettigrew LC, Craddock SD, Culwell AR, Rydel RE, Mattson MP.

J Neurochem. 1994 Aug;63(2):781-4. Erratum in: J Neurochem 1994 Oct;63(4):1585.

PMID:
8035204
26.

Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.

Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN, et al.

Mol Pharmacol. 1994 Mar;45(3):373-9.

PMID:
8145724
27.

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

Mattson MP, Barger SW, Cheng B, Lieberburg I, Smith-Swintosky VL, Rydel RE.

Trends Neurosci. 1993 Oct;16(10):409-14. Review.

PMID:
7504356
28.

beta-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease.

Barger SW, Smith-Swintosky VL, Rydel RE, Mattson MP.

Ann N Y Acad Sci. 1993 Sep 24;695:158-64. Review.

PMID:
8239276
29.
30.

Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.

Mattson MP, Rydel RE, Lieberburg I, Smith-Swintosky VL.

Ann N Y Acad Sci. 1993 May 28;679:1-21. Review.

PMID:
8512177
31.

Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.

Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE.

Neuron. 1993 Feb;10(2):243-54.

PMID:
8094963
32.

beta-Amyloid precursor protein and Alzheimer's disease: the peptide plot thickens.

Mattson MP, Rydel RE.

Neurobiol Aging. 1992 Sep-Oct;13(5):617-21. Review. No abstract available.

PMID:
1461353
33.

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.

Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE.

J Neurosci. 1992 Feb;12(2):376-89.

34.
35.

In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor.

Hatten ME, Lynch M, Rydel RE, Sanchez J, Joseph-Silverstein J, Moscatelli D, Rifkin DB.

Dev Biol. 1988 Feb;125(2):280-9.

PMID:
3338615
40.

Characterization of the effects of autoimmune nerve growth factor deprivation in the developing guinea-pig.

Johnson EM Jr, Osborne PA, Rydel RE, Schmidt RE, Pearson J.

Neuroscience. 1983 Mar;8(3):631-42. No abstract available.

PMID:
6856089
41.

Effects of autoimmune NGF deprivation in the adult rabbit and offspring.

Johnson EM Jr, Gorin PD, Osborne PA, Rydel RE, Pearson J.

Brain Res. 1982 May 20;240(1):131-40.

PMID:
6124306

Supplemental Content

Support Center